• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

调整医疗服务提供者的“开放思维耻辱感量表”以测量与阿片类药物相关的耻辱感。

Adapting the Opening Minds Stigma Scale for Healthcare Providers to Measure Opioid-Related Stigma.

作者信息

Cid Ashley, Patten Alec, Beazely Michael A, Grindrod Kelly

机构信息

School of Pharmacy, University of Waterloo, 10A Victoria St. S, Kitchener, ON N2G 1C5, Canada.

出版信息

Pharmacy (Basel). 2024 Jul 9;12(4):105. doi: 10.3390/pharmacy12040105.

DOI:10.3390/pharmacy12040105
PMID:39051389
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11270195/
Abstract

The opioid crisis in Canada continues to cause a devastating number of deaths. Community-based naloxone programs have been identified as one of the solutions for combatting this crisis; however, there are disparities in which pharmacies stock and offer naloxone. Opioid-related stigma is a major barrier for limited naloxone distribution through pharmacies. Therefore, the development of anti-stigma interventions is crucial to improve naloxone distribution in Canada. However, there is no validated tool to specifically measure opioid-related stigma. The Opening Minds Stigma Scale for Healthcare Providers (OMS-HC) is a validated scale used to measure mental illness-related stigma. This study will adapt the OMS-HC by using four different opioid-related terminologies to determine which is the most stigmatizing to use in an opioid-related anti-stigma intervention. Pharmacy students completed four versions of the adapted OMS-HC. The average OMS-HC scores and Cronbach's α co-efficient were calculated for each version. The term "opioid addiction" was found to be the most stigmatizing term among participants and will be used in the adapted version of the OMS-HC in a future anti-stigma interventions.

摘要

加拿大的阿片类药物危机持续导致大量死亡。基于社区的纳洛酮项目已被视为应对这一危机的解决方案之一;然而,各药店在纳洛酮的储备和供应方面存在差异。与阿片类药物相关的污名是通过药店限制纳洛酮分发的一个主要障碍。因此,开展反污名干预措施对于改善加拿大的纳洛酮分发至关重要。然而,目前尚无专门用于衡量与阿片类药物相关污名的有效工具。医疗保健提供者的开放思维污名量表(OMS-HC)是一种用于衡量与精神疾病相关污名的有效量表。本研究将通过使用四种不同的与阿片类药物相关的术语来改编OMS-HC,以确定在与阿片类药物相关的反污名干预中使用哪种术语最具污名化。药学专业学生完成了改编后的OMS-HC的四个版本。计算了每个版本的OMS-HC平均得分和克朗巴哈α系数。“阿片类药物成瘾”一词在参与者中被发现是最具污名化的术语,并将在未来的反污名干预中用于改编后的OMS-HC版本。

相似文献

1
Adapting the Opening Minds Stigma Scale for Healthcare Providers to Measure Opioid-Related Stigma.调整医疗服务提供者的“开放思维耻辱感量表”以测量与阿片类药物相关的耻辱感。
Pharmacy (Basel). 2024 Jul 9;12(4):105. doi: 10.3390/pharmacy12040105.
2
The development and psychometric properties of a new scale to measure mental illness related stigma by health care providers: the Opening Minds Scale for Health Care Providers (OMS-HC).一种新的衡量医护人员对精神疾病相关污名的量表的开发和心理计量学特性:医护人员开放思维量表(OMS-HC)。
BMC Psychiatry. 2012 Jun 13;12:62. doi: 10.1186/1471-244X-12-62.
3
Opening Minds Stigma Scale for Health Care Providers (OMS-HC): examination of psychometric properties and responsiveness.医疗服务提供者的开放思维污名量表(OMS-HC):心理测量特性与反应性检验
BMC Psychiatry. 2014 Apr 23;14:120. doi: 10.1186/1471-244X-14-120.
4
Psychometric evaluation of the German version of the Opening Minds Stigma Scale for Health Care Providers (OMS-HC).《用于医疗保健提供者的 Opening Minds 污名量表(OMS-HC)德语版的心理测量学评估》。
BMC Psychol. 2021 May 21;9(1):86. doi: 10.1186/s40359-021-00592-9.
5
Validation of the Opening Minds Scale and patterns of stigma in Chilean primary health care.《智利基层医疗中心的敞开心扉量表验证与污名化模式》
PLoS One. 2019 Sep 5;14(9):e0221825. doi: 10.1371/journal.pone.0221825. eCollection 2019.
6
Reducing stigma toward mental illness and substance use issues in primary health care in Chile: Protocol of a cluster controlled trial study.减少智利初级卫生保健中对精神疾病和药物使用问题的污名化:一项整群对照试验研究方案
Front Psychiatry. 2022 Dec 20;13:1083042. doi: 10.3389/fpsyt.2022.1083042. eCollection 2022.
7
Psychometric properties of the Mexican version of the opening minds stigma scale for health care providers (OMS-HC).墨西哥版医疗服务提供者启心障量表(OMS-HC)的心理计量学特性。
PeerJ. 2023 Nov 14;11:e16375. doi: 10.7717/peerj.16375. eCollection 2023.
8
Psychometric properties of the Opening Minds Stigma Scale for Health Care Providers in 32 European countries - A bifactor ESEM representation.32 个欧洲国家卫生保健提供者的《敞开心扉耻辱感量表》的心理测量学特性 - 双因素 ESEM 表示。
Front Public Health. 2023 May 3;11:1168929. doi: 10.3389/fpubh.2023.1168929. eCollection 2023.
9
Validation of the Opening Minds Scale for Health Care Providers (OMS-HC): Factor Structure and Psychometric Properties of the Brazilian Version.医疗保健提供者开放思维量表(OMS-HC)的验证:巴西版本的因子结构和心理测量特性
Healthcare (Basel). 2023 Apr 6;11(7):1049. doi: 10.3390/healthcare11071049.
10
Evaluation of the impact of a social media-focused intervention on reducing mental health stigma among pharmacy students.评估以社交媒体为重点的干预措施对减少药学专业学生心理健康污名化的影响。
Ment Health Clin. 2019 May 10;9(3):110-115. doi: 10.9740/mhc.2019.05.110. eCollection 2019 May.

本文引用的文献

1
Longitudinal evaluation of pharmacists' social distance preference and attitudes toward patients with opioid misuse following an educational training program.教育培训计划对药师对待阿片类药物滥用患者的社会距离偏好和态度的纵向评估。
Subst Abus. 2022;43(1):1051-1056. doi: 10.1080/08897077.2022.2060449.
2
Measuring Stigma Towards People with Opioid Use Problems: Exploratory and Confirmatory Factor Analysis of the Opening Minds Provider Attitudes Towards Opioid-Use Scale (OM-PATOS).测量对有阿片类药物使用问题者的污名化:对“开启心灵——提供者对阿片类药物使用态度量表”(OM-PATOS)的探索性和验证性因素分析
Int J Ment Health Addict. 2022;20(6):3398-3409. doi: 10.1007/s11469-022-00788-z. Epub 2022 Mar 3.
3
Protocol for the Optimizing Naloxone Dispensing in Pharmacies (ONDP) Online Continuing Education Program: A Randomized Controlled Trial.药房优化纳洛酮配药(ONDP)在线继续教育项目方案:一项随机对照试验
Pharmacy (Basel). 2022 Feb 4;10(1):24. doi: 10.3390/pharmacy10010024.
4
The role of pharmacists in opioid stewardship: A scoping review.药剂师在阿片类药物管理中的作用:范围综述。
Res Social Adm Pharm. 2022 May;18(5):2714-2747. doi: 10.1016/j.sapharm.2021.06.018. Epub 2021 Jul 4.
5
Pharmacists' stigma toward patients engaged in opioid misuse: When "social distance" does not mean disease prevention.药剂师对阿片类药物滥用患者的污名化:当“社会距离”并不意味着预防疾病时。
Subst Abus. 2021;42(4):919-926. doi: 10.1080/08897077.2021.1900988. Epub 2021 Mar 22.
6
Efficacy of an Intervention to Reduce Stigma Beliefs and Attitudes among Primary Care and Mental Health Professionals: Two Cluster Randomised-Controlled Trials.干预措施对减少初级保健和精神卫生专业人员的污名化信念和态度的效果:两项集群随机对照试验。
Int J Environ Res Public Health. 2021 Jan 29;18(3):1214. doi: 10.3390/ijerph18031214.
7
What Is Known about Community Pharmacy-Based Take-Home Naloxone Programs and Program Interventions? A Scoping Review.关于基于社区药房的带回家纳洛酮项目及项目干预措施,我们了解哪些内容?一项范围综述。
Pharmacy (Basel). 2021 Feb 2;9(1):30. doi: 10.3390/pharmacy9010030.
8
Factor structure of The Opening Minds Stigma Scale for Health Care Providers and psychometric properties of its Hungarian version.《医疗保健提供者开放思维污名量表》的因子结构及其匈牙利文版本的心理测量学特性。
BMC Psychiatry. 2020 Oct 12;20(1):504. doi: 10.1186/s12888-020-02902-8.
9
"Everything Is Perfect, and We Have No Problems": Detecting and Limiting Social Desirability Bias in Qualitative Research.“一切完美,我们没有问题”:在定性研究中发现和限制社会期望偏差。
Qual Health Res. 2020 Apr;30(5):783-792. doi: 10.1177/1049732319889354. Epub 2019 Dec 13.
10
Implementation of a statewide program within community pharmacies to prevent opioid misuse and accidental overdose.在社区药店实施全州范围内的项目,以防止阿片类药物滥用和意外过量用药。
J Am Pharm Assoc (2003). 2020 Jan-Feb;60(1):117-121. doi: 10.1016/j.japh.2019.09.003. Epub 2019 Oct 31.